COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance Study

REFERENCES

1. 1.↵
   1. Jennette JC,
   2. Falk RJ,
   3. Bacon PA, et al.

   2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Pillebout E,
   2. Sunderkötter C.

   IgA vasculitis. Semin Immunopathol 2021;43:729-38.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Goodman MJ,
   2. Nordin JD,
   3. Belongia EA,
   4. Mullooly JP,
   5. Baggs J.

   Henoch-Schönlein purpura and polysaccharide meningococcal vaccine. Pediatrics 2010;126:e325-9.

   OpenUrlCrossRefPubMed
4. 4.
   1. Watanabe T.

   Vasculitis following influenza vaccination: a review of the literature. Curr Rheumatol Rev 2017;13:188-96.

   OpenUrl
5. 5.↵
   1. Song Y,
   2. Huang X,
   3. Yu G, et al.

   Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol 2021;12:771619.

   OpenUrlPubMed
6. 6.↵
   1. Park JW,
   2. Lagniton PNP,
   3. Liu Y,
   4. Xu RH.

   mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci 2021;17:1446-60.

   OpenUrlCrossRef
7. 7.↵
   1. Chen Y,
   2. Xu Z,
   3. Wang P, et al.

   New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology 2022;165:386-401.

   OpenUrlPubMed
8. 8.↵
   1. Alrashdi Mousa N,
   2. Saleh AM,
   3. Khalid A,
   4. Alshaya AK,
   5. Alanazi SMM.

   Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review. Clin Rheumatol 2022;41:1577-82.

   OpenUrl
9. 9.
   1. Prabhahar A,
   2. Naidu GSRSNK,
   3. Chauhan P, et al.

   ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol Int 2022;42:749-58.

   OpenUrl
10. 10.
    1. Hines AM,
    2. Murphy N,
    3. Mullin C,
    4. Barillas J,
    5. Barrientos JC.

    Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine 2021;39:4571-2.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Sugita K,
    2. Kaneko S,
    3. Hisada R, et al.

    Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review. CEN Case Rep 2022;11:436-41.

    OpenUrl
12. 12.↵
    1. Rasmussen C,
    2. Tisseyre M,
    3. Garon-Czmil J, et al.

    Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev 2021;20:102707.

    OpenUrlPubMed
13. 13.↵
    1. Pham M,
    2. Cheng F,
    3. Ramachandran K.

    A comparison study of algorithms to detect drug-adverse event associations: frequentist, Bayesian, and machine-learning approaches. Drug Saf 2019; 42:743-50.

    OpenUrl
14. 14.↵
    1. Faillie JL.

    Case-non-case studies: principle, methods, bias and interpretation. Therapie 2019;74:225-32.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Raschi E,
    2. Poluzzi E,
    3. Salvo F, et al.

    Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems. Nutr Metab Cardiovasc Dis 2018;28:533-42.

    OpenUrl
16. 16.↵
    1. Norén GN,
    2. Hopstadius J,
    3. Bate A.

    Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res 2013;22:57-69.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Audemard-Verger A,
    2. Pillebout E,
    3. Guillevin L,
    4. Thervet E,
    5. Terrier B.

    IgA vasculitis (Henoch-Shönlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev 2015;14:579-85.

    OpenUrlPubMed
18. 18.↵
    1. Ewer KJ,
    2. Barrett JR,
    3. Belij-Rammerstorfer S, et al.

    T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med 2021;27:270-8.

    OpenUrlPubMed
19. 19.↵
    1. Tarkowski M,
    2. de Jager W,
    3. Schiuma M, et al.

    Anti-SARS-CoV-2 immunoglobulin isotypes, and neutralization activity against viral variants, according to BNT162b2-vaccination and infection history. Front Immunol 2021;12:793191.

    OpenUrl
20. 20.↵
    1. Heineke MH,
    2. Ballering AV,
    3. Jamin A,
    4. Ben Mkaddem S,
    5. Monteiro RC,
    6. Van Egmond M.

    New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Autoimmun Rev 2017;16:1246-53.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Mettler C,
    2. Terrier B,
    3. Treluyer JM,
    4. Chouchana L.

    Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study. Rheumatology 2022;keac323.